Drug Profile
MDR1 gene therapy
Latest Information Update: 07 Jan 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Chemoprotectants; Gene therapies
- Mechanism of Action P-glycoprotein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer